Free Trial
NASDAQ:SMTI

Sanara MedTech (SMTI) Stock Price, News & Analysis

Sanara MedTech logo
$30.87 +1.72 (+5.90%)
As of 03:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Sanara MedTech Stock (NASDAQ:SMTI)

Advanced

Key Stats

Today's Range
$28.81
$30.78
50-Day Range
$28.26
$35.75
52-Week Range
$23.53
$39.08
Volume
26,404 shs
Average Volume
31,992 shs
Market Capitalization
$274.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Consensus Rating
Hold

Company Overview

Sanara MedTech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

SMTI MarketRank™: 

Sanara MedTech scored higher than 48% of companies evaluated by MarketBeat, and ranked 574th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sanara MedTech has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Sanara MedTech has a consensus price target of $50.00, representing about 66.2% upside from its current price of $30.09.

  • Amount of Analyst Coverage

    Sanara MedTech has only been the subject of 2 research reports in the past 90 days.

  • Read more about Sanara MedTech's stock forecast and price target.
  • Earnings Growth

    Earnings for Sanara MedTech are expected to grow in the coming year, from ($1.10) to ($0.97) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sanara MedTech is -25.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sanara MedTech is -25.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sanara MedTech has a P/B Ratio of 6.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Sanara MedTech's valuation and earnings.
  • Percentage of Shares Shorted

    6.64% of the float of Sanara MedTech has been sold short.
  • Short Interest Ratio / Days to Cover

    Sanara MedTech has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Sanara MedTech has recently decreased by 11.03%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sanara MedTech does not currently pay a dividend.

  • Dividend Growth

    Sanara MedTech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.64% of the float of Sanara MedTech has been sold short.
  • Short Interest Ratio / Days to Cover

    Sanara MedTech has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Sanara MedTech has recently decreased by 11.03%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Sanara MedTech insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      42.60% of the stock of Sanara MedTech is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 8.10% of the stock of Sanara MedTech is held by institutions.

    • Read more about Sanara MedTech's insider trading history.
    Receive SMTI Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    SMTI Stock News Headlines

    This Crypto Is Set to Explode in January
    Curious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they understand the why, when, and how of crypto. Join our free 2‑day virtual summit and learn directly from the world’s top hedge fund managers who’ve built real portfolios and real wealth. You’ll walk away with actionable insights grounded in strategy—not hype. No FOMO. No fluff. Just clear steps to move from intrigued to informed about crypto.tc pixel
    Sanara MedTech stock falls after CEO succession announcement
    See More Headlines

    SMTI Stock Analysis - Frequently Asked Questions

    Sanara MedTech's stock was trading at $33.20 at the beginning of the year. Since then, SMTI shares have decreased by 9.4% and is now trading at $30.09.

    Sanara MedTech Inc. (NASDAQ:SMTI) issued its earnings results on Wednesday, August, 13th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.10. The company earned $25.83 million during the quarter, compared to the consensus estimate of $25.15 million. Sanara MedTech had a negative trailing twelve-month return on equity of 26.43% and a negative net margin of 10.22%.
    Read the conference call transcript
    .

    Top institutional shareholders of Sanara MedTech include Stonebridge Wealth Management LLC (1.29%) and Salem Investment Counselors Inc. (0.10%).
    View institutional ownership trends
    .

    Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Sanara MedTech investors own include Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG).

    Company Calendar

    Last Earnings
    8/13/2025
    Today
    10/22/2025
    Next Earnings (Estimated)
    11/12/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED PRODUCTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:SMTI
    CIK
    714256
    Fax
    N/A
    Employees
    60
    Year Founded
    1982

    Price Target and Rating

    High Price Target
    $54.00
    Low Price Target
    $46.00
    Potential Upside/Downside
    +71.5%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.33
    Research Coverage
    3 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($1.16)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$9.66 million
    Net Margins
    -10.22%
    Pretax Margin
    -10.42%
    Return on Equity
    -26.43%
    Return on Assets
    -10.69%

    Debt

    Debt-to-Equity Ratio
    1.25
    Current Ratio
    2.26
    Quick Ratio
    2.03

    Sales & Book Value

    Annual Sales
    $86.67 million
    Price / Sales
    2.99
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $4.45 per share
    Price / Book
    6.55

    Miscellaneous

    Outstanding Shares
    8,900,000
    Free Float
    5,110,000
    Market Cap
    $259.44 million
    Optionable
    Not Optionable
    Beta
    1.21

    Social Links

    A Guide To High-Short-Interest Stocks Cover

    MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:SMTI) was last updated on 10/22/2025 by MarketBeat.com Staff
    From Our Partners